Global and United States Antibody-drug Conjugate Market 2020 by Manufacturers, Type and Application, Forecast to 2025
Market Overview
The global Antibody-drug Conjugate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Antibody-drug Conjugate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Antibody-drug Conjugate market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Antibody-drug Conjugate market has been segmented into Adcetris, Kadcyla, etc.
Breakdown by Application, Antibody-drug Conjugate has been segmented into Breast Cancer, Lymphoma, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antibody-drug Conjugate market presented in the report. This section sheds light on the sales growth of different regional and country-level Antibody-drug Conjugate markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antibody-drug Conjugate market.
For United States, this report analyses the United States market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Antibody-drug Conjugate Market Share Analysis
Antibody-drug Conjugate competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Antibody-drug Conjugate sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antibody-drug Conjugate sales, revenue and market share for each player covered in this report.
The major players covered in Antibody-drug Conjugate are: Agensys, Celldex Therapeutics, Concortis Biotherapeutics, Sanofi, Synthon Holding BV, etc. Among other players domestic and global, Antibody-drug Conjugate market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global Antibody-drug Conjugate market are listed below:
Agensys
Celldex Therapeutics
Concortis Biotherapeutics
Sanofi
Synthon Holding BV
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
Adcetris
Kadcyla
Market segment by Application, can be divided into
Breast Cancer
Lymphoma
Table of Contents
1 Market Overview
1.1 Antibody-drug Conjugate Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antibody-drug Conjugate Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Adcetris
1.2.3 Kadcyla
1.3 Market Analysis by Application
1.3.1 Overview: Global Antibody-drug Conjugate Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Global Antibody-drug Conjugate Market Size and Forecast (2015-2025)
1.4.1 Global Antibody-drug Conjugate Revenue and Forecast (2015-2025)
1.4.2 Global Antibody-drug Conjugate Sales and Forecast (2015-2025)
1.5 Global Antibody-drug Conjugate Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 Agensys
2.1.1 Agensys Details
2.1.2 Agensys Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Agensys SWOT Analysis
2.1.4 Agensys Product and Services
2.1.5 Agensys Antibody-drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Celldex Therapeutics
2.2.1 Celldex Therapeutics Details
2.2.2 Celldex Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Celldex Therapeutics SWOT Analysis
2.2.4 Celldex Therapeutics Product and Services
2.2.5 Celldex Therapeutics Antibody-drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Concortis Biotherapeutics
2.3.1 Concortis Biotherapeutics Details
2.3.2 Concortis Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Concortis Biotherapeutics SWOT Analysis
2.3.4 Concortis Biotherapeutics Product and Services
2.3.5 Concortis Biotherapeutics Antibody-drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sanofi SWOT Analysis
2.4.4 Sanofi Product and Services
2.4.5 Sanofi Antibody-drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Synthon Holding BV
2.5.1 Synthon Holding BV Details
2.5.2 Synthon Holding BV Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Synthon Holding BV SWOT Analysis
2.5.4 Synthon Holding BV Product and Services
2.5.5 Synthon Holding BV Antibody-drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Antibody-drug Conjugate Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Antibody-drug Conjugate Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Antibody-drug Conjugate Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: United States
3.2.1 Key Players Antibody-drug Conjugate Sales in United States (2018-2019)
3.2.2 United States Antibody-drug Conjugate Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Antibody-drug Conjugate Manufacturer Market Share in 2019
3.3.2 Top 6 Antibody-drug Conjugate Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Antibody-drug Conjugate Market Size by Geography (2015-2020)
4.1.1 Global Antibody-drug Conjugate Sales by Geography (2015-2020)
4.1.2 Global Antibody-drug Conjugate Revenue by Regions (2015-2020)
4.2 Global Antibody-drug Conjugate Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Antibody-drug Conjugate Sales and Forecast by Regions (2020-2025)
4.2.2 Global Antibody-drug Conjugate Revenue and Forecast by Regions (2020-2025)
4.3 North America Antibody-drug Conjugate Market Size and Forecast (2015-2025)
4.4 Europe Antibody-drug Conjugate Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Antibody-drug Conjugate Market Size and Forecast (2015-2025)
4.6 South America Antibody-drug Conjugate Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Antibody-drug Conjugate Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Antibody-drug Conjugate Market Size by Country (2015-2020)
5.1.1 North America Antibody-drug Conjugate Sales and Market Share by Country (2015-2020)
5.1.2 North America Antibody-drug Conjugate Revenue and Market Share by Country (2015-2020)
5.2 North America Antibody-drug Conjugate Market Size and Forecast by Country (2020-2025)
5.2.1 North America Antibody-drug Conjugate Sales and Forecast by Country (2020-2025)
5.2.2 North America Antibody-drug Conjugate Revenue and Forecast by Country (2020-2025)
5.3 United States Antibody-drug Conjugate Market Size and Forecast (2015-2025)
5.4 Canada Antibody-drug Conjugate Market Size and Forecast (2015-2025)
5.5 Mexico Antibody-drug Conjugate Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Antibody-drug Conjugate Market Size by Country (2015-2020)
6.1.1 Europe Antibody-drug Conjugate Sales by Country (2015-2020)
6.1.2 Europe Antibody-drug Conjugate Revenue by Country (2015-2020)
6.2 Europe Antibody-drug Conjugate Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Antibody-drug Conjugate Sales and Forecast by Country (2020-2025)
6.2.2 Europe Antibody-drug Conjugate Revenue and Forecast by Country (2020-2025)
6.3 Germany Antibody-drug Conjugate Market Size and Forecast (2015-2025)
6.4 United Kingdom Antibody-drug Conjugate Market Size and Forecast (2015-2025)
6.5 France Antibody-drug Conjugate Market Size and Forecast (2015-2025)
6.6 Russia Antibody-drug Conjugate Market Size and Forecast (2015-2025)
6.7 Italy Antibody-drug Conjugate Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Antibody-drug Conjugate Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Antibody-drug Conjugate Sales by Region (2015-2020)
7.1.2 Asia-Pacific Antibody-drug Conjugate Revenue by Region (2015-2020)
7.2 Asia-Pacific Antibody-drug Conjugate Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Antibody-drug Conjugate Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Antibody-drug Conjugate Revenue and Forecast by Region (2020-2025)
7.3 China Antibody-drug Conjugate Market Size and Forecast (2015-2025)
7.4 Japan Antibody-drug Conjugate Market Size and Forecast (2015-2025)
7.5 Korea Antibody-drug Conjugate Market Size and Forecast (2015-2025)
7.6 India Antibody-drug Conjugate Market Size and Forecast (2015-2025)
7.7 Southeast Asia Antibody-drug Conjugate Market Size and Forecast (2015-2025)
7.8 Australia Antibody-drug Conjugate Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Antibody-drug Conjugate Market Size by Country (2015-2020)
8.1.1 South America Antibody-drug Conjugate Sales by Country (2015-2020)
8.1.2 South America Antibody-drug Conjugate Revenue by Country (2015-2020)
8.2 South America Antibody-drug Conjugate Market Size and Forecast by Country (2020-2025)
8.2.1 South America Antibody-drug Conjugate Sales and Forecast by Country (2020-2025)
8.2.2 South America Antibody-drug Conjugate Revenue and Forecast by Country (2020-2025)
8.3 Brazil Antibody-drug Conjugate Market Size and Forecast (2015-2025)
8.4 Argentina Antibody-drug Conjugate Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Antibody-drug Conjugate Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Antibody-drug Conjugate Sales by Country (2015-2020)
9.1.2 Middle East & Africa Antibody-drug Conjugate Revenue by Country (2015-2020)
9.2 Middle East & Africa Antibody-drug Conjugate Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Antibody-drug Conjugate Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Antibody-drug Conjugate Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Antibody-drug Conjugate Market Size and Forecast (2015-2025)
9.4 Turkey Antibody-drug Conjugate Market Size and Forecast (2015-2025)
9.5 Egypt Antibody-drug Conjugate Market Size and Forecast (2015-2025)
9.6 South Africa Antibody-drug Conjugate Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Antibody-drug Conjugate Market Size by Type (2015-2020)
10.1.1 Global Antibody-drug Conjugate Sales by Type (2015-2020)
10.1.2 Global Antibody-drug Conjugate Revenue by Type (2015-2020)
10.1.3 Global Antibody-drug Conjugate Price by Type (2015-2020)
10.2 Global Antibody-drug Conjugate Market Size and Forecast by Type (2020-2025)
10.2.1 Global Antibody-drug Conjugate Sales and Forecast by Type (2020-2025)
10.2.2 Global Antibody-drug Conjugate Revenue and Forecast by Type (2020-2025)
10.2.3 Global Antibody-drug Conjugate Price and Forecast by Type (2020-2025)
10.3 United States Antibody-drug Conjugate Market Size and Forecast by Type (2015-2025)
10.3.1 United States Antibody-drug Conjugate Market Size by Type (2015-2020)
10.3.2 United States Antibody-drug Conjugate Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Antibody-drug Conjugate Market Size by Application (2015-2020)
11.1.1 Global Antibody-drug Conjugate Sales by Application (2015-2020)
11.1.2 Global Antibody-drug Conjugate Revenue by Application (2015-2020)
11.1.3 Global Antibody-drug Conjugate Price by Application (2015-2020)
11.2 Global Antibody-drug Conjugate Market Size and Forecast by Application (2020-2025)
11.2.1 Global Antibody-drug Conjugate Sales and Forecast by Application (2020-2025)
11.2.2 Global Antibody-drug Conjugate Revenue and Forecast by Application (2020-2025)
11.2.3 Global Antibody-drug Conjugate Price and Forecast by Application (2020-2025)
11.3 United States Antibody-drug Conjugate Market Size and Forecast by Application (2015-2025)
11.3.1 United States Antibody-drug Conjugate Market Size by Application (2015-2020)
11.3.2 United States Antibody-drug Conjugate Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global Antibody-drug Conjugate Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Antibody-drug Conjugate by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Antibody-drug Conjugate Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Antibody-drug Conjugate Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. Agensys Basic Information, Manufacturing Base and Competitors
Table 6. Agensys Antibody-drug Conjugate Major Business
Table 7. Agensys Antibody-drug Conjugate Total Revenue (USD Million) (2018-2019)
Table 8. Agensys SWOT Analysis
Table 9. Agensys Antibody-drug Conjugate Product and Services
Table 10. Agensys Antibody-drug Conjugate Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 11. Celldex Therapeutics Basic Information, Manufacturing Base and Competitors
Table 12. Celldex Therapeutics Antibody-drug Conjugate Major Business
Table 13. Celldex Therapeutics Antibody-drug Conjugate Total Revenue (USD Million) (2018-2019)
Table 14. Celldex Therapeutics SWOT Analysis
Table 15. Celldex Therapeutics Antibody-drug Conjugate Product and Services
Table 16. Celldex Therapeutics Antibody-drug Conjugate Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 17. Concortis Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 18. Concortis Biotherapeutics Antibody-drug Conjugate Major Business
Table 19. Concortis Biotherapeutics Antibody-drug Conjugate Total Revenue (USD Million) (2018-2019)
Table 20. Concortis Biotherapeutics SWOT Analysis
Table 21. Concortis Biotherapeutics Antibody-drug Conjugate Product and Services
Table 22. Concortis Biotherapeutics Antibody-drug Conjugate Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Antibody-drug Conjugate Major Business
Table 25. Sanofi Antibody-drug Conjugate Total Revenue (USD Million) (2018-2019)
Table 26. Sanofi SWOT Analysis
Table 27. Sanofi Antibody-drug Conjugate Product and Services
Table 28. Sanofi Antibody-drug Conjugate Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 29. Synthon Holding BV Basic Information, Manufacturing Base and Competitors
Table 30. Synthon Holding BV Antibody-drug Conjugate Major Business
Table 31. Synthon Holding BV Antibody-drug Conjugate Total Revenue (USD Million) (2018-2019)
Table 32. Synthon Holding BV SWOT Analysis
Table 33. Synthon Holding BV Antibody-drug Conjugate Product and Services
Table 34. Synthon Holding BV Antibody-drug Conjugate Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 35. Global Antibody-drug Conjugate Sales by Manufacturer (2018-2019) (K Units)
Table 36. Global Antibody-drug Conjugate Revenue by Manufacturer (2018-2019) (USD Million)
Table 37. Key Players Antibody-drug Conjugate Sales in United States (2018-2019) (K Units)
Table 38. Key Players Antibody-drug Conjugate Sales Market Share in United States (2018-2019)
Table 39. Key Players Revenue of Antibody-drug Conjugate in United States (2018-2019) (USD Million)
Table 40. Global Antibody-drug Conjugate Sales by Regions (2015-2020) (K Units)
Table 41. Global Antibody-drug Conjugate Sales Market Share by Regions (2015-2020)
Table 42. Global Antibody-drug Conjugate Revenue by Regions (2015-2020) (USD Million)
Table 43. Global Antibody-drug Conjugate Sales and Forecast by Regions (2020-2025) (K Units)
Table 44. Global Antibody-drug Conjugate Sales Market Share by Regions (2020-2025)
Table 45. Global Antibody-drug Conjugate Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 46. Global Antibody-drug Conjugate Revenue Market Share by Regions (2020-2025) (USD Million)
Table 47. North America Antibody-drug Conjugate Sales by Countries (2015-2020) (K Units)
Table 48. North America Antibody-drug Conjugate Sales Market Share by Countries (2015-2020)
Table 49. North America Antibody-drug Conjugate Revenue by Countries (2015-2020) (USD Million)
Table 50. North America Antibody-drug Conjugate Revenue Market Share by Countries (2015-2020)
Table 51. North America Antibody-drug Conjugate Sales by Country (2020-2025) (K Units)
Table 52. North America Antibody-drug Conjugate Sales Market Share by Country (2020-2025)
Table 53. North America Antibody-drug Conjugate Revenue by Country (2020-2025) (USD Million)
Table 54. North America Antibody-drug Conjugate Revenue Market Share by Country (2020-2025)
Table 55. Europe Antibody-drug Conjugate Sales by Countries (2015-2020) (K Units)
Table 56. Europe Antibody-drug Conjugate Sales Market Share by Countries (2015-2020)
Table 57. Europe Antibody-drug Conjugate Revenue by Countries (2015-2020) (USD Million)
Table 58. Europe Antibody-drug Conjugate Revenue Market Share by Countries (2015-2020)
Table 59. Europe Antibody-drug Conjugate Sales by Country (2020-2025) (K Units)
Table 60. Europe Antibody-drug Conjugate Sales Market Share by Country (2020-2025)
Table 61. Europe Antibody-drug Conjugate Revenue by Country (2020-2025) (USD Million)
Table 62. Europe Antibody-drug Conjugate Revenue Market Share by Country (2020-2025)
Table 63. Asia-Pacific Antibody-drug Conjugate Sales by Countries (2015-2020) (K Units)
Table 64. Asia-Pacific Antibody-drug Conjugate Sales Market Share by Countries (2015-2020)
Table 65. Asia-Pacific Antibody-drug Conjugate Revenue by Countries (2015-2020) (USD Million)
Table 66. Asia-Pacific Antibody-drug Conjugate Revenue Market Share by Countries (2015-2020)
Table 67. Asia-Pacific Antibody-drug Conjugate Sales by Country (2020-2025) (K Units)
Table 68. Asia-Pacific Antibody-drug Conjugate Sales Market Share by Country (2020-2025)
Table 69. Asia-Pacific Antibody-drug Conjugate Revenue by Country (2020-2025) (USD Million)
Table 70. Asia-Pacific Antibody-drug Conjugate Revenue Market Share by Country (2020-2025)
Table 71. South America Antibody-drug Conjugate Sales by Countries (2015-2020) (K Units)
Table 72. South America Antibody-drug Conjugate Sales Market Share by Countries (2015-2020)
Table 73. South America Antibody-drug Conjugate Revenue by Countries (2015-2020) (USD Million)
Table 74. South America Antibody-drug Conjugate Revenue Market Share by Countries (2015-2020)
Table 75. South America Antibody-drug Conjugate Sales by Country (2020-2025) (K Units)
Table 76. South America Antibody-drug Conjugate Sales Market Share by Country (2020-2025)
Table 77. South America Antibody-drug Conjugate Revenue by Country (2020-2025) (USD Million)
Table 78. South America Antibody-drug Conjugate Revenue Market Share by Country (2020-2025)
Table 79. Middle East & Africa Antibody-drug Conjugate Sales by Countries (2015-2020) (K Units)
Table 80. Middle East & Africa Antibody-drug Conjugate Sales Market Share by Countries (2015-2020)
Table 81. Middle East & Africa Antibody-drug Conjugate Revenue by Countries (2015-2020) (USD Million)
Table 82. Middle East & Africa Antibody-drug Conjugate Revenue Market Share by Countries (2015-2020)
Table 83. Middle East & Africa Antibody-drug Conjugate Sales by Country (2020-2025) (K Units)
Table 84. Middle East & Africa Antibody-drug Conjugate Sales Market Share by Country (2020-2025)
Table 85. Middle East & Africa Antibody-drug Conjugate Revenue by Country (2020-2025) (USD Million)
Table 86. Middle East & Africa Antibody-drug Conjugate Revenue Market Share by Country (2020-2025)
Table 87. United States Antibody-drug Conjugate Sales by Type (2015-2020) (K Units)
Table 88. United States Antibody-drug Conjugate Sales Market Share by Type (2015-2020)
Table 89. United States Antibody-drug Conjugate Revenue by Type (2015-2020) (USD Million)
Table 90. United States Antibody-drug Conjugate Revenue Market Share by Type (2015-2020)
Table 91. United States Antibody-drug Conjugate Sales by Type (2020-2025) (K Units)
Table 92. United States Antibody-drug Conjugate Sales Market Share by Type (2020-2025)
Table 93. United States Antibody-drug Conjugate Revenue by Type (2020-2025) (USD Million)
Table 94. United States Antibody-drug Conjugate Revenue Market Share by Type (2020-2025)
Table 95. Global Antibody-drug Conjugate Sales by Application (2015-2020) (K Units)
Table 96. Global Antibody-drug Conjugate Sales Market Share by Application (2015-2020)
Table 97. Global Antibody-drug Conjugate Revenue by Application (2015-2020) (USD Million)
Table 98. Global Antibody-drug Conjugate Revenue Market Share by Application (2015-2020)
Table 99. Global Antibody-drug Conjugate Price by Application (2015-2020) (USD/Unit)
Table 100. Global Antibody-drug Conjugate Sales by Application (2020-2025) (K Units)
Table 101. Global Antibody-drug Conjugate Sales Market Share by Application (2020-2025)
Table 102. Global Antibody-drug Conjugate Revenue by Application (2020-2025) (USD Million)
Table 103. Global Antibody-drug Conjugate Revenue Market Share by Application (2020-2025)
Table 104. Global Antibody-drug Conjugate Price by Application (2020-2025) (USD/Unit)
Table 105. United States Antibody-drug Conjugate Sales by Application (2015-2020) (K Units)
Table 106. United States Antibody-drug Conjugate Sales Market Share by Application (2015-2020)
Table 107. United States Antibody-drug Conjugate Revenue by Application (2015-2020) (USD Million)
Table 108. United States Antibody-drug Conjugate Revenue Market Share by Application (2015-2020)
Table 109. United States Antibody-drug Conjugate Sales by Application (2020-2025) (K Units)
Table 110. United States Antibody-drug Conjugate Sales Market Share by Application (2020-2025)
Table 111. United States Antibody-drug Conjugate Revenue by Application (2020-2025) (USD Million)
Table 112. United States Antibody-drug Conjugate Revenue Market Share by Application (2020-2025)
Table 113. Direct Channel Pros & Cons
Table 114. Indirect Channel Pros & Cons
Table 115. Distributors/Traders/ Dealers List
Table 116. Customers of Antibody-drug Conjugate
Table 117. Market Opportunities in Next Few Years
Table 118. Market Risks Analysis
Table 119. Market Drivers
List of Figures
Figure 1. Antibody-drug Conjugate Picture
Figure 2. Global Antibody-drug Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Adcetris Picture
Figure 4. Kadcyla Picture
Figure 5. Antibody-drug Conjugate Sales Market Share by Application in 2019
Figure 6. Breast Cancer Picture
Figure 7. Lymphoma Picture
Figure 8. Global Antibody-drug Conjugate Market Status and Outlook (2015-2025) (USD Million)
Figure 9. Global Antibody-drug Conjugate Sales Growth Rate (2015-2025) (K Units)
Figure 10. Global Antibody-drug Conjugate Sales Market Share by Manufacturer in 2019
Figure 11. Global Antibody-drug Conjugate Revenue Market Share by Manufacturer in 2019
Figure 12. Key Players Antibody-drug Conjugate Revenue Market Share in United States in 2019
Figure 13. Global Top 5 Antibody-drug Conjugate Manufacturer Market Share in 2019
Figure 14. Top 3 Antibody-drug Conjugate Players Market Share in United States in 2019
Figure 15. Global Antibody-drug Conjugate Revenue Market Share by Regions in 2019
Figure 16. North America Antibody-drug Conjugate Sales YoY Growth (2015-2025) (K Units)
Figure 17. North America Antibody-drug Conjugate Revenue YoY Growth (2015-2025) (USD Million)
Figure 18. Europe Antibody-drug Conjugate Sales YoY Growth (2015-2020) (K Units)
Figure 19. Europe Antibody-drug Conjugate Revenue YoY Growth (2015-2020) (USD Million)
Figure 20. Asia-Pacific Antibody-drug Conjugate Sales YoY Growth (2015-2020) (K Units)
Figure 21. Asia-Pacific Antibody-drug Conjugate Revenue YoY Growth (2015-2020) (USD Million)
Figure 22. South America Antibody-drug Conjugate Sales YoY Growth (2015-2020) (K Units)
Figure 23. South America Antibody-drug Conjugate Revenue YoY Growth (2015-2020) (USD Million)
Figure 24. Middle East & Africa Antibody-drug Conjugate Sales YoY Growth (2015-2020) (K Units)
Figure 25. Middle East & Africa Antibody-drug Conjugate Revenue YoY Growth (2015-2020) (USD Million)
Figure 26. North America Antibody-drug Conjugate Sales Market Share by Country in 2019
Figure 27. North America Antibody-drug Conjugate Revenue Market Share by Country in 2019
Figure 28. United States Antibody-drug Conjugate Market Size and Growth Rate (2015-2025) (USD Million)
Figure 29. Canada Antibody-drug Conjugate Market Size and Growth Rate (2015-2025) (USD Million)
Figure 30. Mexico Antibody-drug Conjugate Market Size and Growth Rate (2015-2020) (USD Million)
Figure 31. Europe Antibody-drug Conjugate Revenue Market Share by Country in 2019
Figure 32. Germany Antibody-drug Conjugate Market Size Growth Rate (2015-2025) (USD Million)
Figure 33. United Kingdom Antibody-drug Conjugate Market Size Growth Rate (2015-2025) (USD Million)
Figure 34. France Antibody-drug Conjugate Market Size Growth Rate (2015-2025) (USD Million)
Figure 35. Russia Antibody-drug Conjugate Market Size Growth Rate (2015-2025) (USD Million)
Figure 36. Italy Antibody-drug Conjugate Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. Asia-Pacific Antibody-drug Conjugate Sales Market Share by Region 2018
Figure 38. Asia-Pacific Antibody-drug Conjugate Revenue Market Share by Region 2018
Figure 39. China Antibody-drug Conjugate Market Size Growth Rate (2015-2025) (USD Million)
Figure 40. Japan Antibody-drug Conjugate Market Size Growth Rate (2015-2025) (USD Million)
Figure 41. Korea Antibody-drug Conjugate Market Size Growth Rate (2015-2025) (USD Million)
Figure 42. India Antibody-drug Conjugate Market Size Growth Rate (2015-2025) (USD Million)
Figure 43. Southeast Asia Antibody-drug Conjugate Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Australia Antibody-drug Conjugate Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. South America Antibody-drug Conjugate Sales Market Share by Country in 2019
Figure 46. South America Antibody-drug Conjugate Revenue Market Share by Country in 2019
Figure 47. Brazil Antibody-drug Conjugate Market Size Growth Rate (2015-2025) (USD Million)
Figure 48. Argentina Antibody-drug Conjugate Market Size Growth Rate (2015-2025) (USD Million)
Figure 49. Saudi Arabia Antibody-drug Conjugate Market Size Growth Rate (2015-2025) (USD Million)
Figure 50. Turkey Antibody-drug Conjugate Market Size Growth Rate (2015-2025) (USD Million)
Figure 51. Egypt Antibody-drug Conjugate Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. South Africa Antibody-drug Conjugate Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. Global Revenue Market Share of Antibody-drug Conjugate by Type in 2019
Figure 54. Global Revenue Market Share of Antibody-drug Conjugate by Application in 2019
Figure 55. Sales Channel: Direct Channel vs Indirect Channel
Companies Mentioned
Agensys
Celldex Therapeutics
Concortis Biotherapeutics
Sanofi
Synthon Holding BV
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets